|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Madersbacher S, Hochreiter W, Burkhard F,
Thalmann GN, Danuser H, Markwalder R and Studer UE: Radical
cystectomy for bladder cancer today-a homogeneous series without
neoadjuvant therapy. J Clin Oncol. 21:690–696. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Volanis D, Papadopoulos G, Doumas K,
Gkialas I and Delakas D: Molecular mechanisms in urinary bladder
carcinogenesis. J BUON. 16:589–601. 2011.PubMed/NCBI
|
|
5
|
Chen Z, Zhou L, Liu X, Wang L, Kazobinka
G, Zhang X and Hou T: Loss of Fezf2 promotes malignant progression
of bladder cancer by regulating the NF-κB signaling pathway. Lab
Invest. 98:1225–1236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soria F, D'Andrea D, Pohar K, Shariat SF
and Lotan Y: Diagnostic, prognostic and surveillance urinary
markers in nonmuscle invasive bladder cancer: Any role in clinical
practice? Curr Opin Urol. 27–Aug;2018.(Epub ahead of print).
View Article : Google Scholar
|
|
7
|
Chew CS, Chen X, Parente JA Jr, Tarrer S,
Okamoto C and Qin HY: Lasp-1 binds to non-muscle F-actin in vitro
and is localized within multiple sites of dynamic actin assembly in
vivo. J Cell Sci. 115:4787–4799. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Terasaki AG, Suzuki H, Nishioka T,
Matsuzawa E, Katsuki M, Nakagawa H, Miyamoto S and Ohashi K: A
novel LIM and SH3 protein (lasp-2) highly expressing in chicken
brain. Biochem Biophys Res Commun. 313:48–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li B, Zhuang L and Trueb B: Zyxin
interacts with the SH3 domains of the cytoskeletal proteins
LIM-nebulette and Lasp-1. J Biol Chem. 279:20401–20410. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kadrmas JL and Beckerle MC: The LIM
domain: From the cytoskeleton to the nucleus. Nat Rev Mol Cell
Biol. 5:920–931. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stradal TE and Scita G: Protein complexes
regulating Arp2/3-mediated actin assembly. Curr Opin Cell Biol.
18:4–10. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng XA, Norris A, Panaviene Z and Moncman
CL: Ectopic expression of LIM-nebulette (LASP2) reveals roles in
cell migration and spreading. Cell Motil Cytoskeleton. 65:827–840.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Cai L, Zhou H, Liu Y, Fan C, Wang
L, Li A, Miao Y, Li Q, Qiu X and Wang E: Lasp2 enhances tumor
invasion via facilitating phosphorylation of FAK and predicts poor
overall survival of non-small cell lung cancer patients. Mol
Carcinog. 56:2558–2565. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang B, Zhang L and Zhao L, Zhou R, Ding
Y, Li G and Zhao L: LASP2 suppresses colorectal cancer progression
through JNK/p38 MAPK pathway meditated epithelial-mesenchymal
transition. Cell Commun Signal. 15:212017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang C, Zhang W, Wang L, Kazobinka G, Han
X, Li B and Hou T: Musashi-2 promotes migration and invasion in
bladder cancer via activation of the JAK2/STAT3 pathway. Lab
Invest. 96:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang G and McKenney JK: Urinary bladder
pathology: World Health Organization (WHO) classification and
american joint committee on cancer (AJCC) staging update. Arch
Pathol Lab Med. 25–Jul;2018.(Epub ahead of print). View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kazmierski ST, Antin PB, Witt CC, Huebner
N, McElhinny AS, Labeit S and Gregorio CC: The complete mouse
nebulin gene sequence and the identification of cardiac nebulin. J
Mol Biol. 328:835–846. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pappas CT, Bliss KT, Zieseniss A and
Gregorio CC: The Nebulin family: An actin support group. Trends
Cell Biol. 21:29–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Romero NB, Lehtokari VL, Quijano-Roy S,
Monnier N, Claeys KG, Carlier RY, Pellegrini N, Orlikowski D,
Barois A, Laing NG, et al: Core-rod myopathy caused by mutations in
the nebulin gene. Neurology. 73:1159–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ehler E, Horowits R, Zuppinger C, Price
RL, Perriard E, Leu M, Caroni P, Sussman M, Eppenberger HM and
Perriard JC: Alterations at the intercalated disk associated with
the absence of muscle LIM protein. J Cell Biol. 153:763–772. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katoh M and Katoh M: Identification and
characterization of LASP2 gene in silico. Int J Mol Med.
12:405–410. 2003.PubMed/NCBI
|
|
24
|
Zieseniss A, Terasaki AG and Gregorio CC:
Lasp-2 expression, localization, and ligand interactions: A new
Z-disc scaffolding protein. Cell Motil Cytoskeleton. 65:59–72.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Panaviene Z and Moncman CL: Linker region
of nebulin family members plays an important role in targeting
these molecules to cellular structures. Cell Tissue Res.
327:353–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu X, Feng JR, Wang F, Chen PF, Chen XX,
Zhou R, Chang Y, Liu J and Zhao Q: Profiles of differentially
expressed genes and overexpression of NEBL indicates a positive
prognosis in patients with colorectal cancer. Mol Med Rep.
17:3028–3034. 2018.PubMed/NCBI
|
|
27
|
Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng
Q, Wang F and Yuan J: LIM and SH3 domain protein 1 (LASP-1)
overexpression was associated with aggressive phenotype and poor
prognosis in clear cell renal cell cancer. PLoS One. 9:e1005572014.
View Article : Google Scholar : PubMed/NCBI
|
